Skip to content
Screener

West Pharmaceutical Services WST Finance Lease Liabilities (Total)

Finance Lease Liabilities (Total) at other companies

AptarGroup logo
AptarGroupATR
$24.32M+3.9%
Sonoco Products logo
Sonoco ProductsSON
$53.57M-22.3%
UFP Technologies logo
UFP TechnologiesUFPT
$14K-78.1%
Trimas logo
TrimasTRS
$1.19M-25.6%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$5.79M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$9.85M-65.5%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.53B+43.8%
Enterprise value$24.41B+44.8%
P/E43.4×+8.4×
P/S7.4×+1.6×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099
($ in millions) / YearOperating LeasesFinance Leases
202721.41.5
202820.51.1
202915.10.6
203010.40.4
Thereafter53.50.4
134.94.7
Less: imputed lease interest(25.7)(0.3)
Total lease liabilities$109.2$4.4

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is West Pharmaceutical Services's finance lease liabilities (total)?
West Pharmaceutical Services (WST) reported finance lease liabilities (total) of $4.4M in Q2 2026.
How has West Pharmaceutical Services's finance lease liabilities (total) changed year-over-year?
West Pharmaceutical Services's finance lease liabilities (total) decreased by 10.2% year-over-year, from $4.9M to $4.4M.
What does finance lease liabilities (total) mean?
Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.

Ask your AI about West Pharmaceutical Services's finance lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude